Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy

ABSTRACT:

SUBMITTER: Wei A 

PROVIDER: S-EPMC12914422 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature